Tether freezes 131 ISIS-K-linked wallets
Tether froze USDT linked to 131 TRON wallets after the United States Treasury's Office of Foreign Assets Control added 134 cryptocurrency wallet identifiers connected to ISIS-K to its sanctions list.

Crypto journalist for Grafa, with nearly 10 years of experience covering blockchain, Web3, and NFT gaming trends. MBA & Economics grad.
Tether froze USDT linked to 131 TRON wallets after the United States Treasury's Office of Foreign Assets Control added 134 cryptocurrency wallet identifiers connected to ISIS-K to its sanctions list.
Imricor Medical Systems (ASX:IMR) has secured US regulatory clearances to expand its products across 250 paediatric hospitals.
Telix Pharmaceuticals (ASX:TLX) aligned with the US regulator to advance its Phase 3 trial after a 36-patient safety study.
American Bitcoin shares fell 8.4% to a record low of US$0.62 after the company confirmed a 1-for-15 reverse stock split designed to maintain compliance with Nasdaq's minimum listing requirements.
US-listed spot Bitcoin exchange-traded funds recorded a record US$4.5 billion in net outflows during June, exceeding the US$1.25 billion Strategy is authorised to raise through its recently announced Bitcoin monetisation programme.
Crédit Agricole, through its CACEIS asset servicing division, launched the EURXT euro-backed stablecoin on the Ethereum (CRYPTO:ETH) blockchain with an initial supply of 20.02 million tokens backed by approximately €20.02 million in reserves.
Peter Warren Automotive (ASX:PWR) said vendors of Wakeling Automotive will not extend the deadline for the proposed $28 million acquisition.
Tether's USDT (CRYPTO:USDT) has been removed from regulated European cryptocurrency exchanges after the European Union's Markets in Crypto-Assets framework required licensed platforms to support only authorised stablecoins.
Northern Star Resources (ASX:NST) appointed Suresh Vadnagra as Managing Director and CEO, effective Oct. 5.
Artelo Biosciences (NASDAQ:ARTL) reported new preclinical data for ART26.12, a selective FABP5 inhibitor currently in Phase 1 development, in a mouse model of spinal cord injury–related neuropathic pain.